News - ANANTA

News

MHRA Drops Post-Op Pain Use for Prolonged-Release Opioids

14.03.2025

MHRA Drops Post-Op Pain Use for Prolonged-Release Opioids

Ananta Medicare took part in the scientific and practical conference ‘Topical issues of modern urology, nephrology and urogynecology: personalised approaches to treatment’

12.03.2025

Ananta Medicare took part in the scientific and practical conference ‘Topical issues of modern urology, nephrology and urogynecology: personalised approaches to treatment’

Hemophilia A: Gene Therapy a Game Changer

03.03.2025

Hemophilia A: Gene Therapy a Game Changer

Virtual Reality Shows Promise in Motor Function Recovery

20.02.2025

Virtual Reality Shows Promise in Motor Function Recovery

Ananta Medicare Ukraine participated in an online conference for gynecologists, obstetricians, and family doctors

19.02.2025

Ananta Medicare Ukraine participated in an online conference for gynecologists, obstetricians, and family doctors

Ritlecitinib Shows Long-Term Benefits in Alopecia Areata

06.02.2025

Ritlecitinib Shows Long-Term Benefits in Alopecia Areata

Adding PD-1 Inhibitor to Chemoradiation Boosts Complete Response in Resectable Esophageal Cancer

28.01.2025

Adding PD-1 Inhibitor to Chemoradiation Boosts Complete Response in Resectable Esophageal Cancer

On January 3, 2025, a significant event in the field of Ukrainian dermatology took place in the ancient city of Lviv – the DERMATOLOGICAL MALANKA, where the pharmaceutical company Ananta Medicare participated as a sponsor

21.01.2025

On January 3, 2025, a significant event in the field of Ukrainian dermatology took place in the ancient city of Lviv – the DERMATOLOGICAL MALANKA, where the pharmaceutical company Ananta Medicare participated as a sponsor

TONZIHELP: A New Remedy for Throat Health!

17.01.2025

TONZIHELP: A New Remedy for Throat Health!

Ananta Medicare has introduced a new product, RENISTIL

14.01.2025

Ananta Medicare has introduced a new product, RENISTIL